lobbying_activities: 1258608

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
1258608	1417d12b-9115-4cac-9d6e-5aa8c779b0e1	Q2	RED+BLUE STRATEGIES	400693064	PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION (PCMA)	2012	second_quarter	HCR	P.L. 112-25 - The Budget Control Act of 2011. Focused on changes that could impact Medicare, Medicaid and the private market with regard to prescription drug benefits. H.R. 1946 Preserving Our Hometown Independent Pharmacies Act of 2011, which allows for an antitrust exception for certain pharmacies. Work focused on Health Reform Law-related regulations specific to Essential Health Benefits provisions. Monitoring potential provisions focused on Medicare Part D and PBM-focused policies for end of year wrap up bills. Issues related to the implementation of the Health Reform law that impact public and private sector pharmacy benefits. S. 3187 - FDA Safety and Innovation Act - Issues related to supply chain safety, treatment of controlled substances and REMS policies. Specific issues regarding Medicaid surveys for pharmacies, including specialty and mail order.	Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE	60000		0	0	2012-07-06T14:03:01.527000-04:00